Drug recall · November 1, 2017
Enalapril Maleate tablets recall
Why: Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;
- Lots / codes
Lot # DR10635, EXP 05/2019; DR10636, EXP 05/2019.
- Quantity
- 5050 bottles
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- Nationwide in the USA
- Initiated
- August 22, 2017 · Voluntary: Firm initiated
- Classified
- October 26, 2017
- Reported
- November 1, 2017
- Ended
- February 27, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Enalapril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.